123 related articles for article (PubMed ID: 38686510)
1. Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.
Iwaki S; Kawakita D; Nagao T; Tada Y; Honma Y; Ando M; Matoba T; Minohara K; Nakano S; Murase T; Iwasaki S; Inagaki H
Int J Cancer; 2024 Apr; ():. PubMed ID: 38686510
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
3. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
Wang K; Russell JS; McDermott JD; Elvin JA; Khaira D; Johnson A; Jennings TA; Ali SM; Murray M; Marshall C; Oldham DS; Washburn D; Wong SJ; Chmielecki J; Yelensky R; Lipson D; Miller VA; Stephens PJ; Serracino HS; Ross JS; Bowles DW
Clin Cancer Res; 2016 Dec; 22(24):6061-6068. PubMed ID: 27334835
[TBL] [Abstract][Full Text] [Related]
4. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract][Full Text] [Related]
5. Genetic landscape of 482 thyroid carcinomas: analysis with the national datacenter for cancer genomic medicine in Japan.
Yamazaki H; Kunisaki C; Sugimori M; Rino Y; Saito A
Endocrine; 2024 Feb; ():. PubMed ID: 38407696
[TBL] [Abstract][Full Text] [Related]
6. Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics.
Xi Q; Kage H; Ogawa M; Matsunaga A; Nishijima A; Sone K; Kawana K; Oda K
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201563
[TBL] [Abstract][Full Text] [Related]
7. HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis.
Egebjerg K; Harwood CD; Woller NC; Kristensen CA; Mau-Sørensen M
Front Oncol; 2021; 11():693394. PubMed ID: 34249747
[TBL] [Abstract][Full Text] [Related]
8. Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review.
Ferrell JK; Mace JC; Clayburgh D
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1135-1146. PubMed ID: 30649610
[TBL] [Abstract][Full Text] [Related]
9. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors.
Bou Zerdan M; Kumar PA; Zaccarini D; Ross J; Huang R; Sivapiragasam A
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831055
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness.
Moriwaki K; Ayani Y; Kuwabara H; Terada T; Higashino M; Kawata R
Oral Oncol; 2024 Apr; 151():106751. PubMed ID: 38479153
[TBL] [Abstract][Full Text] [Related]
12. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
13. Advances and challenges in precision medicine in salivary gland cancer.
Lassche G; van Boxtel W; Ligtenberg MJL; van Engen-van Grunsven ACH; van Herpen CML
Cancer Treat Rev; 2019 Nov; 80():101906. PubMed ID: 31644971
[TBL] [Abstract][Full Text] [Related]
14. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
Dogan S; Ng CKY; Xu B; Kumar R; Wang L; Edelweiss M; Scott SN; Zehir A; Drilon A; Morris LGT; Lee NY; Antonescu CR; Ho AL; Katabi N; Berger MF; Reis-Filho JS
Hum Pathol; 2019 Jun; 88():66-77. PubMed ID: 30946933
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Molecular Profiling of Oncocytic Salivary Gland Malignancies.
Zaccarini DJ; Sivapiragasam A; Sokol E; Huang RSP; Pavlick DC; Janovitz T; Nasr MR; Ross JS
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):609-613. PubMed ID: 35876752
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Kurzrock R; Bowles DW; Kang H; Meric-Bernstam F; Hainsworth J; Spigel DR; Bose R; Burris H; Sweeney CJ; Beattie MS; Blotner S; Schulze K; Cuchelkar V; Swanton C
Ann Oncol; 2020 Mar; 31(3):412-421. PubMed ID: 32067683
[TBL] [Abstract][Full Text] [Related]
17. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.
Maruya S; Shirasaki T; Nagaki T; Kakehata S; Kurotaki H; Mizukami H; Shinkawa H
BMC Cancer; 2009 Feb; 9():72. PubMed ID: 19250538
[TBL] [Abstract][Full Text] [Related]
19. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
[TBL] [Abstract][Full Text] [Related]
20. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
Rooper LM; Gagan J; Bishop JA
Head Neck Pathol; 2022 Dec; 16(4):1063-1072. PubMed ID: 35794510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]